BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) Institutional Ownership

13F Institutional Holders and Ownership History from Q3 2024 to Q4 2025

Type / Class
Equity / Common Stock, par value $0.00001 per share
Symbol
BIOA on Nasdaq
Shares outstanding
35,872,648
Price per share
$13.23
All holders as of 30 Sep 2025
Q3 2025
Total 13F shares
21,259,082
Total reported value
$125,003,330
% of total 13F portfolios
0%
Share change
+518,829
Value change
+$3,516,038
Number of holders
92
Price from insider filings
$13.23
Reported Shares, Excluding Options vs Price
Reported Value, Excluding Options
Total Investors

Significant Owners of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) based on Schedule 13D/G filings

Filer Ownership Change % Holdings Value Net Change Nb Shares Change % Reporting Name Report Period
Cormorant Asset Management, LP 6% -20% $8,840,699 -$2,019,256 2,140,605 -19% Cormorant Asset Management, LP 30 Jun 2025
ADAR1 Capital Management, LLC 5.4% $8,000,318 1,937,123 ADAR1 Capital Management, LLC 30 Jun 2025
RA CAPITAL MANAGEMENT, L.P. 3.7% $5,740,380 1,310,589 RA Capital Management, L.P. 31 Dec 2024

As of 30 Sep 2025, 92 institutional investors reported holding 21,259,082 shares of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA). This represents 59% of the company’s total 35,872,648 outstanding shares.

Top 25 Institutional Shareholders

The largest institutional shareholders of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) together control 56% of the company’s outstanding shares — a level of ownership often associated with strong institutional conviction and long‑term capital commitment.

Institution Ownership % Shares Held Share Change % Portfolio % Holdings Value
a16z Capital Management, L.L.C. 9% 3,233,170 0% 1.4% $19,011,040
Sofinnova Investments, Inc. 6.4% 2,293,788 -0.48% 0.83% $13,487,473
Cormorant Asset Management, LP 6% 2,140,605 0% 0.87% $12,586,757
ADAR1 Capital Management, LLC 5.2% 1,880,073 -2.9% 1.1% $11,054,829
VANGUARD GROUP INC 4.6% 1,651,247 +6% 0% $9,709,331
TANG CAPITAL MANAGEMENT LLC 4.5% 1,600,000 0% 0.36% $9,408,000
BlackRock, Inc. 3.6% 1,279,621 -0.61% 0% $7,524,172
ORBIMED ADVISORS LLC 2.2% 790,901 -14% 0.11% $4,650,498
Sands Capital Alternatives, LLC 2.2% 786,353 0% 1% $4,623,756
Pivotal bioVenture Partners Investment Advisor LLC 1.8% 653,374 0% 2.2% $3,841,839
GEODE CAPITAL MANAGEMENT, LLC 1.6% 562,731 +24% 0% $3,310,050
REDPOINT MANAGEMENT, LLC 1.1% 383,254 0% 1.4% $2,253,534
Siren, L.L.C. 1.1% 382,406 0% 0.09% $2,248,547
MILLENNIUM MANAGEMENT LLC 0.85% 306,552 +750% 0% $1,802,526
Comprehensive Financial Management LLC 0.76% 271,842 0% 0.04% $1,598,431
MORGAN STANLEY 0.64% 228,158 +6.9% 0% $1,341,569
JACOBS LEVY EQUITY MANAGEMENT, INC 0.59% 213,088 -22% 0% $1,252,957
STATE STREET CORP 0.55% 198,111 +23% 0% $1,164,893
CHARLES SCHWAB INVESTMENT MANAGEMENT INC 0.53% 191,383 +59% 0% $1,125,332
Stonepine Capital Management, LLC 0.53% 188,571 +25% 0.9% $1,108,797
NORTHERN TRUST CORP 0.52% 186,568 +22% 0% $1,097,020
MARSHALL WACE, LLP 0.49% 174,196 -23% 0% $1,024,272
RENAISSANCE TECHNOLOGIES LLC 0.4% 143,000 +60% 0% $840,840
LOS ANGELES CAPITAL MANAGEMENT LLC 0.34% 120,929 0% $711,063
CITADEL ADVISORS LLC 0.32% 114,063 +4.1% 0% $670,690

Institutional Holders of BioAge Labs, Inc. - Common Stock, par value $0.00001 per share (BIOA) across Reporting Periods

Period Reported Shares, Excl. Options Value, Excl. Options Value Change Price (Median) Investors
2025 Q4 10,494 $138,837 +$133,054 $13.23 4
2025 Q3 21,259,082 $125,003,330 +$3,516,038 $5.88 92
2025 Q2 20,716,453 $85,559,282 +$3,327,577 $4.13 81
2025 Q1 20,278,591 $76,157,053 +$1,658,645 $3.76 65
2024 Q4 19,641,111 $113,720,000 -$68,696,192 $5.79 64
2024 Q3 20,709,688 $430,774,211 +$424,388,861 $20.80 58